Faculty of Medical Science, University College London, London, UK.
Faculty of Medical Science, University College London, London, UK.
Eur Urol Focus. 2019 Jan;5(1):62-68. doi: 10.1016/j.euf.2017.03.016. Epub 2017 Apr 19.
Multiparametric magnetic resonance imaging (mp-MRI) is becoming an increasingly important diagnostic tool for prostate cancer. So far there has been little focus on management for indeterminate mp-MRI results.
To describe outcomes for a cohort of men rated as having an indeterminate mp-MRI result.
DESIGN, SETTING, AND PARTICIPANTS: Patients were identified retrospectively from a single UK centre between October 2010 and January 2015. Patients were included if they had a Likert score of 3/5 on a first MRI scan without any prior prostate biopsy. Patients were offered one of two initial management strategies. Strategy 1 was an immediate targeted biopsy of the MRI lesion. Strategy 2 was a surveillance process comprising prostate-specific antigen monitoring and/or mp-MRI at intervals of 6-12 mo, with biopsy on a for-cause basis.
Cancer detection and treatment outcomes were compared for the two strategies.
Of 168 patients, 73 (43%) chose strategy 1 and 95 (57%) chose strategy two. The overall proportion of men with clinically significant cancer detected was 14% (23/168). The risk profile for cancer identified in the initial surveillance group was similar to that identified in the immediate biopsy group. Limitations of the study include the short follow-up.
Men with indeterminate mp-MRI were willing to forego immediate biopsy for a strategy of surveillance involving PSA measurement and/or mp-MRI repeated at intervals. The risk profile of the cancers identified by both strategies appeared similar, but many men in the surveillance group avoided the risks, complications, and costs of biopsy. Long-term results are awaited.
This report compares two approaches for an uncertain magnetic resonance imaging result for clinically important prostate cancer: immediate biopsy versus surveillance with delayed biopsy if required. Delayed biopsy did not result in identification of cancer with adverse features, and many men benefited from avoiding a biopsy and its complications.
多参数磁共振成像(mp-MRI)正成为前列腺癌越来越重要的诊断工具。到目前为止,对不确定的 mp-MRI 结果的管理关注甚少。
描述一组被评估为具有不确定 mp-MRI 结果的男性患者的结局。
设计、地点和参与者:本研究回顾性地从 2010 年 10 月至 2015 年 1 月英国的一个单一中心确定了患者。如果患者的首次 MRI 扫描的 Likert 评分为 3/5,且无先前的前列腺活检史,则将其纳入研究。患者接受了两种初始管理策略之一。策略 1 是对 MRI 病变进行即刻靶向活检。策略 2 是包括前列腺特异性抗原监测和(或)mp-MRI 在内的随访方案,间隔为 6-12 个月,必要时进行活检。
比较了两种策略的癌症检出和治疗结局。
在 168 名患者中,73 名(43%)选择了策略 1,95 名(57%)选择了策略 2。总的来说,有 14%(23/168)的男性发现有临床显著的癌症。在初始监测组中发现的癌症的风险特征与在即刻活检组中发现的风险特征相似。本研究的局限性包括随访时间较短。
对于不确定的 mp-MRI,男性愿意选择包含 PSA 测量和(或)mp-MRI 重复的监测策略,而不是立即进行活检。两种策略发现的癌症的风险特征似乎相似,但监测组中的许多男性避免了活检的风险、并发症和费用。有待观察长期结果。
本报告比较了两种用于有临床意义的前列腺癌的不确定磁共振成像结果的方法:即刻活检与需要时的延迟活检。延迟活检并未导致发现具有不良特征的癌症,许多男性受益于避免活检及其并发症。